Andover, MA, United States of America

Isabelle Draper

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Children's Medical Center Corporation, Tufts University. Active years: 2017.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Isabelle Draper

Introduction

Isabelle Draper is a notable inventor based in Andover, MA (US). She has made significant contributions to the field of medical science, particularly in the treatment of muscular diseases. Her innovative approaches have the potential to improve the quality of life for many individuals suffering from these conditions.

Latest Patents

Isabelle Draper holds a patent for "Compounds and methods for the treatment of muscular disease, and related screening methods." This patent discloses methods of treating muscle diseases and enhancing normal muscle function by administering a therapeutically effective amount of an isoprenoid antibiotic. Additionally, it describes methods for upregulating hnRNP L and its targets, as well as screening compounds for their efficacy in treating muscle diseases.

Career Highlights

Throughout her career, Isabelle has worked with esteemed organizations such as Tufts Medical Center, Inc. and Children's Medical Center Corporation. Her work in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Isabelle has collaborated with notable colleagues, including Louis M Kunkel and Matthew S Alexander. These partnerships have further enriched her research and innovation efforts.

Conclusion

Isabelle Draper's contributions to the field of muscular disease treatment exemplify the impact of innovative thinking in medical science. Her work continues to inspire future advancements in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…